On May 14, 2019 Molecular Templates, Inc., (Nasdaq: MTEM) a clinical stage biopharmaceutical company focused on the discovery and development of Engineered Toxin Bodies (ETBs), a new class of targeted biologic therapies that possess unique mechanisms of action in oncology, reported that Eric Poma, Ph.D., Chief Executive Officer and Chief Scientific Officer, will present a corporate overview at the Oppenheimer New York Oncology Insight Summit, and the UBS Global Healthcare Conference, both taking place in New York City (Press release, Molecular Templates, MAY 14, 2019, View Source [SID1234536267]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Oppenheimer New York Oncology Insight Summit
Date: Thursday, May 16
Format: One-on-One Meetings

UBS Global Healthcare Conference
Date: Monday, May 20
Time: 8:00am Eastern Time
Format: Fireside Chat
Webcast: https://cc.talkpoint.com/ubsx001/052019a_as/?entity=62_RJ1HXDS